Ray Co

Ray Co Rule of 40

The Rule of 40 of Ray Co (228670.KQ) as of Nov 18, 2026 is 30.64 %. In the previous year, Rule of 40 was -105.84 % — a change of -128.95% (higher).

Rule of 40

30.64 %

YoY

-128.95%

Last updated:

Rule of 40 of Ray Co is 2025 30.64 % . Rule of 40 of Ray Co was 2024 -105.84 % . It decreases by -128.95% higher compared to the previous year.

The Ray Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
68.23 KRW
Jan 1, 2019
59.46 KRW
Jan 1, 2020
-16.19 KRW
Jan 1, 2021
64.83 KRW
Jan 1, 2022
55.36 KRW
Jan 1, 2023
14.35 KRW
Jan 1, 2024
-105.84 KRW
Jan 1, 2025
30.64 KRW
The Ray Co Rule of 40 history
YEARRule of 40YoY
30.64 %-128.95%
-105.84 %-837.70%
14.35 %-74.08%
55.36 %-14.61%
64.83 %-500.40%
-16.19 %-127.23%
59.46 %-12.86%
68.23 %+126.13%
30.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Rule of 40 of Ray Co is 30.64 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Ray Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Ray Co

All Key Metrics — Ray Co